Drug Profile
Clioquinol - Gerolymatos Group/Alterity Therapeutics
Alternative Names: Chloroiodoquine; Gero-46; Iodochlorhydroxyquin; Iodochlorhydroxyquinoline; PBT-1Latest Information Update: 05 Nov 2021
Price :
$50
*
At a glance
- Originator Gerolymatos Group; Prana Biotechnology
- Class Antibacterials; Antidementias; Antifungals; Antiprotozoals; Hydroxyquinolines; Ionophores; Small molecules
- Mechanism of Action Chelating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 08 Apr 2019 Prana Biotechnology is now called Alterity Therapeutics
- 11 Apr 2005 Discontinued - Phase-II for Alzheimer's disease in Australia (unspecified route)
- 04 Jan 2005 Prana Biotechnology has received a CTA from the UK MHRA to initiate a phase II/III trial